Staar Surgical (STAA) Total Non-Current Liabilities (2010 - 2026)
Staar Surgical's (STAA) quarterly Total Non-Current Liabilities came in at $98.7 million in Q2 2026, down 8.05% YoY from $107.3 million in Q2 2025, and down 8.14% on a QoQ basis from $107.4 million in Q1 2026.
Staar Surgical (STAA) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Staar Surgical (STAA) has 17 years of Total Non-Current Liabilities data on file, last reported at $98.7 million in Q2 2026.
- Quarterly Total Non-Current Liabilities fell 8.05% year-over-year to $98.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $98.7 million (down 8.05% YoY) and the FY2026 annual result came in at $107.4 million, down 4.19% from the prior year.
- Total Non-Current Liabilities declined to $98.7 million in Q2 2026, from $107.4 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $112.1 million in Q4 2024 to a low of $74.4 million in Q3 2022.
- A 5-year average of $94.8 million and a median of $99.7 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities jumped 45.21% — and 2026, when it slipped 8.05%.
- Tracing STAA's Total Non-Current Liabilities over 5 years: stood at $82.5 million in 2022, then advanced by 24.43% to $102.6 million in 2023, then rose by 9.27% to $112.1 million in 2024, then retreated by 8.57% to $102.5 million in 2025, then decreased by 3.74% to $98.7 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $98.7 million (Q2 2026), $107.4 million (Q1 2026), and $102.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Staar Surgical | 1.16 Bn | 978.41 Mn | 69.73 Mn | 109.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 109.76 Mn |
| Apr 3, 2026 | 98.71 Mn |
| Jan 2, 2026 | 107.45 Mn |
| Sep 26, 2025 | 102.54 Mn |
| Jun 27, 2025 | 101.16 Mn |
| Mar 28, 2025 | 107.35 Mn |
| Dec 27, 2024 | 112.15 Mn |
| Sep 27, 2024 | 109.34 Mn |
| Jun 28, 2024 | 103.53 Mn |
| Mar 29, 2024 | 99.65 Mn |
| Dec 29, 2023 | 102.64 Mn |
| Sep 29, 2023 | 92.83 Mn |
| Jun 30, 2023 | 86.85 Mn |
| Mar 31, 2023 | 79.76 Mn |
| Dec 30, 2022 | 82.49 Mn |
| Sep 30, 2022 | 74.39 Mn |
| Jul 1, 2022 | 76.55 Mn |
| Apr 1, 2022 | 74.67 Mn |
| Dec 31, 2021 | 87.02 Mn |
| Oct 1, 2021 | 75.29 Mn |